KRAS and malignant colon neoplasm: Tumors with KRAS codon 13 mutants, in comparison with RAS wild-type colon cancers were more likely to exhibit lower total LN rate (P = 0.05), and the majority of LN were significantly less than 12 (P = 0.05).